Checchi Capital Advisers, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 878 filers reported holding NOVARTIS A G in Q2 2016. The put-call ratio across all filers is 1.16 and the average weighting 0.5%.

Quarter-by-quarter ownership
Checchi Capital Advisers, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$1,874,020
+3.3%
18,398
+2.3%
0.17%
+7.4%
Q2 2023$1,814,866
+14.0%
17,985
+3.9%
0.16%
+5.2%
Q1 2023$1,591,784
-0.0%
17,302
-1.4%
0.15%
-6.7%
Q4 2022$1,592,227
+18.5%
17,551
-0.8%
0.16%
+31.0%
Q3 2022$1,344,000
-11.4%
17,687
+0.1%
0.13%
-3.8%
Q2 2022$1,517,000
+9.7%
17,676
+12.1%
0.13%
+11.0%
Q1 2022$1,383,000
+1.1%
15,766
+0.8%
0.12%
-1.7%
Q4 2021$1,368,000
+6.5%
15,634
-0.5%
0.12%
-5.5%
Q3 2021$1,285,000
-9.3%
15,713
+1.2%
0.13%
-9.3%
Q2 2021$1,417,000
-0.5%
15,527
-6.8%
0.14%
-0.7%
Q1 2021$1,424,000
-9.0%
16,659
+0.5%
0.14%
-12.4%
Q4 2020$1,565,000
+3.7%
16,576
-4.5%
0.16%
-3.6%
Q3 2020$1,509,000
+5.3%
17,352
+5.7%
0.17%
-2.3%
Q2 2020$1,433,000
+8.2%
16,412
+2.1%
0.17%
+34.6%
Q1 2020$1,325,000
-4.9%
16,076
+9.2%
0.13%
-31.7%
Q4 2019$1,393,000
-4.2%
14,715
-12.1%
0.19%
-1.6%
Q3 2019$1,454,000
-6.9%
16,733
-2.1%
0.19%
-4.5%
Q2 2019$1,561,000
-6.9%
17,093
-2.0%
0.20%
+1.0%
Q1 2019$1,677,000
+23.0%
17,443
+9.9%
0.20%
+11.4%
Q4 2018$1,363,000
-14.1%
15,878
-13.8%
0.18%
-3.8%
Q3 2018$1,587,000
+4.7%
18,419
-8.2%
0.18%
-3.7%
Q2 2018$1,516,000
+13.7%
20,075
+21.7%
0.19%
+8.0%
Q1 2018$1,333,000
-1.6%
16,489
+2.2%
0.18%
-3.3%
Q4 2017$1,355,000
-1.8%
16,141
+0.4%
0.18%
+30.9%
Q3 2017$1,380,000
-12.3%
16,071
-14.7%
0.14%
-18.7%
Q2 2017$1,573,000
+37.5%
18,844
+22.4%
0.17%
+29.5%
Q1 2017$1,144,000
+18.7%
15,397
+16.3%
0.13%
+1.5%
Q4 2016$964,000
-18.4%
13,239
-11.5%
0.13%
-2.3%
Q3 2016$1,181,000
-19.7%
14,961
-16.1%
0.13%
-20.8%
Q2 2016$1,470,000
+20.2%
17,822
+5.6%
0.17%
-38.2%
Q1 2016$1,223,000
-10.5%
16,879
+6.3%
0.27%
-21.2%
Q4 2015$1,366,000
-16.0%
15,879
-10.2%
0.34%
-21.8%
Q3 2015$1,626,000
+6.7%
17,687
+14.1%
0.44%
+9.7%
Q2 2015$1,524,000
+12.6%
15,496
+12.9%
0.40%
+0.5%
Q1 2015$1,354,000
+21.5%
13,728
+14.1%
0.40%
-4.3%
Q4 2014$1,114,000
+5.1%
12,027
+6.8%
0.42%
-3.9%
Q3 2014$1,060,000
+16.0%
11,258
+11.6%
0.44%
+4.3%
Q2 2014$914,000
+33.0%
10,091
+24.8%
0.42%
-1.0%
Q1 2014$687,000
+5.2%
8,084
-0.4%
0.42%
-17.1%
Q4 2013$653,0008,1190.51%
Other shareholders
NOVARTIS A G shareholders Q2 2016
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders